RNA-mediated CRISPR-Cas13 inhibition through crRNA structural mimicry.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 40273258.
- Also identified by DOI 10.1126/science.adr3656 and PMC identifier 12118380.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To circumvent CRISPR-Cas immunity, phages express anti-CRISPR factors that inhibit the expression or activities of Cas proteins. Whereas most anti-CRISPRs described to date are proteins, recently described small RNAs called RNA anti-CRISPRs (rAcrs) have sequence homology to CRISPR RNAs (crRNAs) and displace them from cognate Cas nucleases. In this work, we report the discovery of rAcrVIA1-a plasmid-encoded small RNA that inhibits the RNA-targeting CRISPR-Cas13 system in its natural host, <i>Listeria seeligeri</i>. We solved the cryo-electron microscopy structure of the Cas13-rAcr complex, which revealed that rAcrVIA1 adopts a fold nearly identical to crRNA despite sharing negligible sequence similarity. Collectively, our findings expand the diversity of rAcrs and reveal an example of immune antagonism through RNA structural mimicry.
Medical subject headings
- Bacteriophages
- CRISPR-Associated Proteins
- CRISPR-Cas Systems
- Listeria
- Molecular Mimicry
- RNA, Viral
- RNA, Small Untranslated